Using Targeted Treatments in Patients With Metastatic Urothelial Cancer

Physicians Discuss Sequencing of Sacituzumab Govitecan in Bladder Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Pedro C. Barata, MD, MSc, and participants discussed when in sequence they would use sacituzumab govitecan for patients with metastatic urothelial cancer. This is the second of 2 articles based on this event.

Sacituzumab Govitecan Shows Efficacy in Pretreated Urothelial Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Pedro C. Barata, MD, MSc, discussed data supporting the use of sacituzumab govitecan in advanced urothelial carcinoma.